The Discounted Cash Flow (DCF) valuation of Turning Point Therapeutics Inc (TPTX) is (20,190.35) USD. With the latest stock price at 76.01 USD, the upside of Turning Point Therapeutics Inc based on DCF is -26662.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 7.9% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (65,813.16) - (11,975.57) | (20,190.35) |
| Upside | -86684.9% - -15855.3% | -26662.8% |